Extract from “Three vital reasons we oppose the TPPA”

Under the agreement, pharmaceutical companies, which are among those enjoying access to negotiators as “advisers”, can challenge any attempt to make generic drugs more affordable by claiming that such measures undermine their new rights granted by the (TPPA) deal. In the financial sector, the agreement will water down regulatory safeguards put in place after the 2008 financial crisis and block any ban placed on risky financial products, including those toxic derivatives that contributed to the crisis in the first place.

Loading data

Welcome to TPP Debate!
What's your stance?

TPPDebate.org is a crowd-sourced platform to debate the Trans-Pacific Partnership Agreement (TPP). What does everyone think about the TPP? What is your stance?